Topics

GlaxoSmithKline wins Benlysta US label expansion for children

09:13 EDT 30 Apr 2019 | PharmaTimes

The approval marks the first medicine in the US approved for children with systemic lupus erythematosus.

Original Article: GlaxoSmithKline wins Benlysta US label expansion for children

NEXT ARTICLE

More From BioPortfolio on "GlaxoSmithKline wins Benlysta US label expansion for children"

Quick Search

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Lupus
Lupus is a complex and poorly understood condition that affects many parts of the body and causes symptoms ranging from mild to life-threatening. There are several types of lupus. The main types are: discoid lupus erythematosus drug-induced lu...